Similar heart failure hospitalization and survival benefits are associated with Sacubitril/Valsartan therapy in CRT non responders and in HFrEF patients with no CRT indication
25 August 2023 (07:30 - 18:30)
Organised by: 

About the speaker

University of Debrecen, Debrecen (Hungary)
6 More presentations in this session
Doctor F. Memenga (Hamburg, DE)
Access the full session
The Event
ESC Congress 2023
25 August - 28 August 2023


